- Report
- August 2025
- 184 Pages
Global
From €3447EUR$3,939USD£2,988GBP
- Report
- October 2025
- 250 Pages
Global
From €3930EUR$4,490USD£3,406GBP
- Report
- January 2026
- 268 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- October 2025
- 164 Pages
Global
From €4070EUR$4,650USD£3,527GBP
- Report
- February 2025
- 185 Pages
Global
From €4070EUR$4,650USD£3,527GBP
- Report
- January 2026
- 180 Pages
Global
From €3447EUR$3,939USD£2,988GBP
- Report
- May 2025
- 220 Pages
Global
From €5207EUR$5,950USD£4,513GBP
- Report
- September 2025
- 147 Pages
Global
From €3500EUR$3,999USD£3,033GBP
- Report
- March 2025
- 148 Pages
Global
From €3500EUR$3,999USD£3,033GBP
- Report
- June 2025
- 147 Pages
Global
From €4288EUR$4,900USD£3,717GBP
- Report
- January 2026
- 272 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 483 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 174 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 180 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 195 Pages
Global
From €3447EUR$3,939USD£2,988GBP
- Report
- January 2026
- 188 Pages
Global
From €3447EUR$3,939USD£2,988GBP
- Report
- January 2026
- 192 Pages
Global
From €3447EUR$3,939USD£2,988GBP
- Report
- January 2026
- 187 Pages
Global
From €3447EUR$3,939USD£2,988GBP
- Report
- January 2026
- 180 Pages
Global
From €3447EUR$3,939USD£2,988GBP
- Report
- November 2025
- 189 Pages
Global
From €3447EUR$3,939USD£2,988GBP

Epilepsy is a neurological disorder characterized by recurrent seizures. It affects people of all ages and is one of the most common neurological disorders worldwide. Treatment options for epilepsy include medications, lifestyle changes, and surgery. The goal of treatment is to reduce the frequency and severity of seizures.
The epilepsy market is a subset of the larger neurology market. It is composed of pharmaceutical companies, medical device companies, and other healthcare providers. Pharmaceutical companies develop and market antiepileptic drugs (AEDs) to treat epilepsy. Medical device companies develop and market devices such as vagus nerve stimulators and responsive neurostimulators to treat epilepsy. Other healthcare providers, such as neurologists, provide diagnosis and treatment of epilepsy.
Some companies in the epilepsy market include Pfizer, GlaxoSmithKline, Johnson & Johnson, Medtronic, Abbott, and UCB. Show Less Read more